|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
21 June 2021 |
|
Main ID: |
NCT04930952 |
|
Date of registration:
|
11/06/2021 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Complications of Ethanol-amine Oleate Intralesional Sclerotherapy
|
|
Scientific title:
|
Complications of Ethanol-amine Oleate Intralesional Sclerotherapy Injections of Maxillofacial Venous Malformations in Pediatric Patients |
|
Date of first enrolment:
|
February 28, 2019 |
|
Target sample size:
|
15 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT04930952 |
|
Study type:
|
Observational [Patient Registry] |
|
Study design:
|
|
|
Phase:
|
|
|
|
Countries of recruitment
|
|
Egypt
| | | | | | | |
|
Contacts
|
|
Name:
|
Sarah Arafat, MSc |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Assistant Lecturer |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria: maxillofacial venous malformation
-
Exclusion Criteria:
1. Patients with lung, liver, or kidney diseases
2. Patients with Klippel-Trenaunay syndrome
3. Patients mental or physical disabilities
Age minimum:
N/A
Age maximum:
12 Years
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Venous Malformation
|
|
Intervention(s)
|
|
Drug: Ethanol-amine Oleate Sclerotherapy Injection
|
|
Primary Outcome(s)
|
|
Clinical Response
[Time Frame: 12 months]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|